-
1
-
-
0004257938
-
-
Lippencott Williams & Wilkins, New York
-
Paul WE. Fundamental Immunology, Lippencott Williams & Wilkins, New York 2003.
-
(2003)
Fundamental Immunology
-
-
Paul, W.E.1
-
3
-
-
64949085560
-
Therapeutic antibodies: Current state and future trends-is a paradigm change coming soon?
-
Dimitrov DS, Marks JD. Therapeutic antibodies: Current state and future trends-is a paradigm change coming soon? Meth Mol Biol 2009; 525:1-27.
-
(2009)
Meth Mol Biol
, vol.525
, pp. 1-27
-
-
Dimitrov, D.S.1
Marks, J.D.2
-
4
-
-
0016756272
-
Continuous cultures of fused cells secreting antibody of predefined specificity
-
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495-497
-
(1975)
Nature
, vol.256
, pp. 495-497
-
-
Kohler, G.1
Milstein, C.2
-
5
-
-
0021818675
-
Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface
-
Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315-1317
-
(1985)
Science
, vol.228
, pp. 1315-1317
-
-
Smith, G.P.1
-
6
-
-
0024461313
-
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
-
DOI 10.1038/341544a0
-
Ward ES, Gussow D, Griffiths AD, Jones PT, Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989; 341:544-546 (Pubitemid 19252529)
-
(1989)
Nature
, vol.341
, Issue.6242
, pp. 544-546
-
-
Ward, E.S.1
Gussow, D.2
Griffiths, A.D.3
Jones, P.T.4
Winter, G.5
-
7
-
-
0024833055
-
Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda
-
Huse WD, Sastry L, Iverson SA, Kang AS, ting-Mees M, Burton DR, et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989; 246:1275-1281
-
(1989)
Science
, vol.246
, pp. 1275-1281
-
-
Huse, W.D.1
Sastry, L.2
Iverson, S.A.3
Kang, A.S.4
Ting-Mees, M.5
Burton, D.R.6
-
8
-
-
0025838698
-
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals
-
Burton DR, Barbas CF, Persson MA, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991; 88:10134-10137 (Pubitemid 21915789)
-
(1991)
Proceedings of the National Academy of Sciences of the United States of America
, vol.88
, Issue.22
, pp. 10134-10137
-
-
Burton, D.R.1
Barbas III, C.F.2
Persson, M.A.A.3
Koenig, S.4
Changcr, R.M.5
Lerner, R.A.6
-
9
-
-
0026317443
-
By-passing immunization. Human antibodies from V-gene libraries displayed on phage
-
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581-597
-
(1991)
J Mol Biol
, vol.222
, pp. 581-597
-
-
Marks, J.D.1
Hoogenboom, H.R.2
Bonnert, T.P.3
McCafferty, J.4
Griffiths, A.D.5
Winter, G.6
-
12
-
-
0037350545
-
Immunotherapy: Past, present and future
-
Waldmann TA. Immunotherapy: past, present and future. Nat Med 2003; 9:269-277
-
(2003)
Nat Med
, vol.9
, pp. 269-277
-
-
Waldmann, T.A.1
-
13
-
-
33646352962
-
Potent antibody therapeutics by design
-
Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343-357
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 343-357
-
-
Carter, P.J.1
-
14
-
-
62349132009
-
Monoclonal antibodies for cancer immunotherapy
-
Weiner LM, Dhodapkar MV, Ferrone S. Monoclonal antibodies for cancer immunotherapy. Lancet 2009; 373:1033-1040
-
(2009)
Lancet
, vol.373
, pp. 1033-1040
-
-
Weiner, L.M.1
Dhodapkar, M.V.2
Ferrone, S.3
-
15
-
-
57049155399
-
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
-
Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov 2008; 7:1001-1012
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 1001-1012
-
-
Ashkenazi, A.1
-
16
-
-
60849128549
-
Monoclonal antibodies as innovative therapeutics
-
Reichert JM. Monoclonal antibodies as innovative therapeutics. Curr Pharm Biotechnol 2008; 9:423-430
-
(2008)
Curr Pharm Biotechnol
, vol.9
, pp. 423-430
-
-
Reichert, J.M.1
-
17
-
-
0036719574
-
Antibodies, viruses and vaccines
-
Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol 2002; 2:706-713
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 706-713
-
-
Burton, D.R.1
-
18
-
-
38049094546
-
Antibody-based HIV-1 vaccines: Recent developments and future directions
-
Montefiori D, Sattentau Q, Flores J, Esparza J, Mascola J. Antibody-based HIV-1 vaccines: recent developments and future directions. PLoS Med 2007; 4:348.
-
(2007)
PLoS Med
, vol.4
, pp. 348
-
-
Montefiori, D.1
Sattentau, Q.2
Flores, J.3
Esparza, J.4
Mascola, J.5
-
19
-
-
33646421976
-
Prophylactic human papillomavirus vaccines
-
Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006; 116:1167-1173
-
(2006)
J Clin Invest
, vol.116
, pp. 1167-1173
-
-
Lowy, D.R.1
Schiller, J.T.2
-
20
-
-
43849094005
-
Cardiotoxicity profile of trastuzumab
-
Ewer SM, Ewer MS. Cardiotoxicity profile of trastuzumab. Drug Saf 2008; 31:459-467
-
(2008)
Drug Saf
, vol.31
, pp. 459-467
-
-
Ewer, S.M.1
Ewer, M.S.2
-
21
-
-
33748416499
-
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
-
DOI 10.1056/NEJMoa063842
-
Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355:1018-1028 (Pubitemid 44343545)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.10
, pp. 1018-1028
-
-
Suntharalingam, G.1
Perry, M.R.2
Ward, S.3
Brett, S.J.4
Castello-Cortes, A.5
Brunner, M.D.6
Panoskaltsis, N.7
-
23
-
-
60049093113
-
Preclinical efficacy and safety models for mAbs: The challenge of developing effective model systems
-
Dixit R, Coats S. Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems. IDrugs 2009; 12:103-108
-
(2009)
IDrugs
, vol.12
, pp. 103-108
-
-
Dixit, R.1
Coats, S.2
-
24
-
-
46149098675
-
Managing premedications and the risk for reactions to infusional monoclonal antibody therapy
-
Chung CH. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Oncologist 2008; 13:725-732
-
(2008)
Oncologist
, vol.13
, pp. 725-732
-
-
Chung, C.H.1
-
26
-
-
54849437047
-
Prediction of immunogenicity: In silico paradigms, ex vivo and in vivo correlates
-
De Groot AS, McMurry J, Moise L. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. Curr Opin Pharmacol 2008; 8:620-626
-
(2008)
Curr Opin Pharmacol
, vol.8
, pp. 620-626
-
-
De Groot, A.S.1
McMurry, J.2
Moise, L.3
-
27
-
-
62249171454
-
Strategies for preclinical immunogenicity assessment of protein therapeutics
-
Stas P, Lasters I. Strategies for preclinical immunogenicity assessment of protein therapeutics. IDrugs 2009; 12:169-173
-
(2009)
IDrugs
, vol.12
, pp. 169-173
-
-
Stas, P.1
Lasters, I.2
-
29
-
-
64249160740
-
Reducing the immunogenicity of protein therapeutics
-
Onda M. Reducing the immunogenicity of protein therapeutics. Curr Drug Targets 2009; 10:131-139
-
(2009)
Curr Drug Targets
, vol.10
, pp. 131-139
-
-
Onda, M.1
-
30
-
-
46149124807
-
How to predict and prevent the immunogenicity of therapeutic proteins
-
DOI 10.1016/S1387-2656(08)00007-0, PII S1387265608000070
-
Schellekens H. How to predict and prevent the immunogenicity of therapeutic proteins. Biotechnol Annu Rev 2008; 14:191-202. (Pubitemid 351903454)
-
(2008)
Biotechnology Annual Review
, vol.14
, pp. 191-202
-
-
Schellekens, H.1
-
31
-
-
0038476357
-
Immunogenicity of therapeutic monoclonal antibodies
-
Pendley C, Schantz A, Wagner C. Immunogenicity of therapeutic monoclonal antibodies. Curr Opin Mol Ther 2003; 5:172-179
-
(2003)
Curr Opin Mol Ther
, vol.5
, pp. 172-179
-
-
Pendley, C.1
Schantz, A.2
Wagner, C.3
-
33
-
-
33344479421
-
Antiviral antibody responses: The two extremes of a wide spectrum
-
DOI 10.1038/nri1783
-
Hangartner L, Zinkernagel RM, Hengartner H. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 2006; 6:231-243 (Pubitemid 43290992)
-
(2006)
Nature Reviews Immunology
, vol.6
, Issue.3
, pp. 231-243
-
-
Hangartner, L.1
Zinkernagel, R.M.2
Hengartner, H.3
-
34
-
-
70349769842
-
Human immunoglobulin allotypes: Possible implications for immunogenicity
-
Jefferis R, Lefranc MP. Human immunoglobulin allotypes: Possible implications for immunogenicity. mAbs 2009; 1:332-338
-
(2009)
MAbs
, vol.1
, pp. 332-338
-
-
Jefferis, R.1
Lefranc, M.P.2
-
35
-
-
67149139366
-
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-inf liximab
-
Magdelaine-Beuzelin C, Vermeire S, Goodall M, Baert F, Noman M, Assche GV, et al. IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-inf liximab. Pharmacogenet Genomics 2009; 19:383-387
-
(2009)
Pharmacogenet Genomics
, vol.19
, pp. 383-387
-
-
Magdelaine-Beuzelin, C.1
Vermeire, S.2
Goodall, M.3
Baert, F.4
Noman, M.5
Assche, G.V.6
-
36
-
-
45149122101
-
Newer monoclonal antibodies for hematological malignancies
-
DOI 10.1016/j.exphem.2008.04.018, PII S0301472X08002075
-
Castillo J, Winer E, Quesenberry P. Newer monoclonal antibodies for hematological malignancies. Exp Hematol 2008; 36:755-768 (Pubitemid 351826873)
-
(2008)
Experimental Hematology
, vol.36
, Issue.7
, pp. 755-768
-
-
Castillo, J.1
Winer, E.2
Quesenberry, P.3
-
37
-
-
59549083317
-
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
-
Mariani G, Fasolo A, De BE, Gianni L. Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer. Nat Clin Pract Oncol 2009; 6:93-104.
-
(2009)
Nat Clin Pract Oncol
, vol.6
, pp. 93-104
-
-
Mariani, G.1
Fasolo, A.2
De, B.E.3
Gianni, L.4
-
38
-
-
60849094827
-
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer
-
Bedard PL, Piccart-Gebhart MJ. Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer. Clin Breast Cancer 2008; 8:157-165
-
(2008)
Clin Breast Cancer
, vol.8
, pp. 157-165
-
-
Bedard, P.L.1
Piccart-Gebhart, M.J.2
-
39
-
-
57649183358
-
Current perspective-trastuzumab
-
Hall PS, Cameron DA. Current perspective-trastuzumab. Eur J Cancer 2009; 45:12-18
-
(2009)
Eur J Cancer
, vol.45
, pp. 12-18
-
-
Hall, P.S.1
Cameron, D.A.2
-
40
-
-
56549113680
-
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: Updated efficacy and biomarker analyses
-
Cameron D, Casey M, Press M, Lindquist D, Pienkowski T, Romieu CG, et al. A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses. Breast Cancer Res Treat 2008; 112:533-543
-
(2008)
Breast Cancer Res Treat
, vol.112
, pp. 533-543
-
-
Cameron, D.1
Casey, M.2
Press, M.3
Lindquist, D.4
Pienkowski, T.5
Romieu, C.G.6
-
41
-
-
55849130720
-
Novel anti-angiogenic therapies for malignant gliomas
-
Norden AD, Drappatz J, Wen PY. Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 2008; 7:1152-1160
-
(2008)
Lancet Neurol
, vol.7
, pp. 1152-1160
-
-
Norden, A.D.1
Drappatz, J.2
Wen, P.Y.3
-
42
-
-
58149232648
-
Evolution of bevacizumabbased therapy in the management of breast cancer
-
Sachdev JC, Jahanzeb M. Evolution of bevacizumabbased therapy in the management of breast cancer. Clin Breast Cancer 2008; 8:402-410
-
(2008)
Clin Breast Cancer
, vol.8
, pp. 402-410
-
-
Sachdev, J.C.1
Jahanzeb, M.2
-
43
-
-
55549105059
-
Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer
-
Patel DK. Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer. Pharmacotherapy 2008; 28:31-41.
-
(2008)
Pharmacotherapy
, vol.28
, pp. 31-41
-
-
Patel, D.K.1
-
44
-
-
65549152525
-
Monoclonal antibody therapies for solid tumors
-
Tassev DV, Cheung NK. Monoclonal antibody therapies for solid tumors. Expert Opin Biol Ther 2009; 9:341-353
-
(2009)
Expert Opin Biol Ther
, vol.9
, pp. 341-353
-
-
Tassev, D.V.1
Cheung, N.K.2
-
45
-
-
38449090309
-
Monoclonal antibody therapy for prostate cancer
-
Jakobovits A. Monoclonal antibody therapy for prostate cancer. Handb Exp Pharmacol 2008; 237-256
-
(2008)
Handb Exp Pharmacol
, pp. 237-256
-
-
Jakobovits, A.1
-
46
-
-
65549170425
-
Mechanisms of tumor resistance to EGFR-targeted therapies
-
Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opin Ther Targets 2009; 13:339-362
-
(2009)
Expert Opin Ther Targets
, vol.13
, pp. 339-362
-
-
Hopper-Borge, E.A.1
Nasto, R.E.2
Ratushny, V.3
Weiner, L.M.4
Golemis, E.A.5
Astsaturov, I.6
-
47
-
-
55949131238
-
Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent crossreactive HIV-1 neutralizers
-
Chen W, Zhu Z, Feng Y, Dimitrov DS. Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent crossreactive HIV-1 neutralizers. Proc Natl Acad Sci USA 2008; 105:17121-17126
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 17121-17126
-
-
Chen, W.1
Zhu, Z.2
Feng, Y.3
Dimitrov, D.S.4
-
48
-
-
48549105161
-
Molecular engineering and design of therapeutic antibodies
-
Presta LG. Molecular engineering and design of therapeutic antibodies. Curr Opin Immunol 2008; 20:460-470
-
(2008)
Curr Opin Immunol
, vol.20
, pp. 460-470
-
-
Presta, L.G.1
-
49
-
-
61649087668
-
Glycosylation as a strategy to improve antibody-based therapeutics
-
Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009; 8:226-234
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 226-234
-
-
Jefferis, R.1
-
51
-
-
52949085848
-
Ertumaxomab: A trifunctional antibody for breast cancer treatment
-
Kiewe P, Thiel E. Ertumaxomab: a trifunctional antibody for breast cancer treatment. Expert Opin Investig Drugs 2008; 17:1553-1558
-
(2008)
Expert Opin Investig Drugs
, vol.17
, pp. 1553-1558
-
-
Kiewe, P.1
Thiel, E.2
-
52
-
-
61349114199
-
Ipilimumab: Controversies in its development, utility and autoimmune adverse events
-
Weber J. Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol Immunother 2009; 58:823-830
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 823-830
-
-
Weber, J.1
-
53
-
-
58149483422
-
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
-
Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, et al. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc Natl Acad Sci USA 2008; 105:20410-20415
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 20410-20415
-
-
Yuan, J.1
Gnjatic, S.2
Li, H.3
Powel, S.4
Gallardo, H.F.5
Ritter, E.6
-
54
-
-
62449168519
-
TRAIL agonists on clinical trials for cancer therapy: The promises and the challenges
-
Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 2009; 4:34-41.
-
(2009)
Rev Recent Clin Trials
, vol.4
, pp. 34-41
-
-
Bellail, A.C.1
Qi, L.2
Mulligan, P.3
Chhabra, V.4
Hao, C.5
-
55
-
-
10744226328
-
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library
-
DOI 10.1016/j.jim.2003.07.003
-
Zhang MY, Shu Y, Phogat S, Xiao X, Cham F, Bouma P, et al. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. J Immunol Methods 2003; 283:17-25. (Pubitemid 37501056)
-
(2003)
Journal of Immunological Methods
, vol.283
, Issue.1-2
, pp. 17-25
-
-
Zhang, M.-Y.1
Shu, Y.2
Phogat, S.3
Xiao, X.4
Cham, F.5
Bouma, P.6
Choudhary, A.7
Feng, Y.-R.8
Sanz, I.9
Rybak, S.10
Broder, C.C.11
Quinnan Jr., G.V.12
Evans, T.13
Dimitrov, D.S.14
-
56
-
-
34247569794
-
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning
-
DOI 10.1016/j.jim.2006.09.016, PII S0022175906002675
-
Zhang MY, Choudhry V, Sidorov IA, Tenev V, Vu BK, Choudhary A, et al. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. J Immunol Methods 2006; 317:21-30. (Pubitemid 44822553)
-
(2006)
Journal of Immunological Methods
, vol.317
, Issue.1-2
, pp. 21-30
-
-
Zhang, M.-Y.1
Choudhry, V.2
Sidorov, I.A.3
Tenev, V.4
Vu, B.K.5
Choudhary, A.6
Lu, H.7
Stiegler, G.M.8
Katinger, H.W.D.9
Jiang, S.10
Broder, C.C.11
Dimitrov, D.S.12
-
57
-
-
33846175669
-
Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency
-
Zhang MY, Dimitrov DS. Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency. Curr Pharm Des 2007; 13:203-212
-
(2007)
Curr Pharm des
, vol.13
, pp. 203-212
-
-
Zhang, M.Y.1
Dimitrov, D.S.2
-
58
-
-
67949120214
-
A large library based on a novel (CH2) scaffold: Identification of HIV-1 inhibitors
-
Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS. A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors. Biochem Biophys Res Commun 2009; 387:387-392
-
(2009)
Biochem Biophys Res Commun
, vol.387
, pp. 387-392
-
-
Xiao, X.1
Feng, Y.2
Vu, B.K.3
Ishima, R.4
Dimitrov, D.S.5
-
59
-
-
52449112071
-
Heterogeneity of monoclonal antibodies
-
Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci 2008; 97:2426-2447
-
(2008)
J Pharm Sci
, vol.97
, pp. 2426-2447
-
-
Liu, H.1
Gaza-Bulseco, G.2
Faldu, D.3
Chumsae, C.4
Sun, J.5
-
61
-
-
58749110914
-
Implementation of advanced technologies in commercial monoclonal antibody production
-
Zhou JX, Tressel T, Yang X, Seewoester T. Implementation of advanced technologies in commercial monoclonal antibody production. Biotechnol J 2008; 3:1185-1200
-
(2008)
Biotechnol J
, vol.3
, pp. 1185-1200
-
-
Zhou, J.X.1
Tressel, T.2
Yang, X.3
Seewoester, T.4
-
62
-
-
67449097168
-
Challenges in monoclonal antibody-based therapies
-
Samaranayake H, Wirth T, Schenkwein D, Raty JK, Yla-Herttuala S. Challenges in monoclonal antibody-based therapies. Ann Med 2009; 41:322-331
-
(2009)
Ann Med
, vol.41
, pp. 322-331
-
-
Samaranayake, H.1
Wirth, T.2
Schenkwein, D.3
Raty, J.K.4
Yla-Herttuala, S.5
-
63
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220
-
(2009)
N Engl J Med
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
Pitisuttithum, P.2
Nitayaphan, S.3
Kaewkungwal, J.4
Chiu, J.5
Paris, R.6
-
64
-
-
62049083943
-
Structural and functional bases for broadspectrum neutralization of avian and human influenza a viruses
-
Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, et al. Structural and functional bases for broadspectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009; 16:265-273
-
(2009)
Nat Struct Mol Biol
, vol.16
, pp. 265-273
-
-
Sui, J.1
Hwang, W.C.2
Perez, S.3
Wei, G.4
Aird, D.5
Chen, L.M.6
-
66
-
-
64849114224
-
Antibody recognition of a highly conserved influenza virus epitope
-
Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009; 324:246-251
-
(2009)
Science
, vol.324
, pp. 246-251
-
-
Ekiert, D.C.1
Bhabha, G.2
Elsliger, M.A.3
Friesen, R.H.4
Jongeneelen, M.5
Throsby, M.6
-
67
-
-
67651017498
-
Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
-
Kubota-Koketsu R, Mizuta H, Oshita M, Ideno S, Yunoki M, Kuhara M, et al. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem Biophys Res Commun 2009; 387:180-185
-
(2009)
Biochem Biophys Res Commun
, vol.387
, pp. 180-185
-
-
Kubota-Koketsu, R.1
Mizuta, H.2
Oshita, M.3
Ideno, S.4
Yunoki, M.5
Kuhara, M.6
-
68
-
-
47649095674
-
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: Insights into vaccine-associated Guillain-Barre syndrome
-
DOI 10.1086/589624
-
Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barre syndrome. J Infect Dis 2008; 198:226-233 (Pubitemid 352019288)
-
(2008)
Journal of Infectious Diseases
, vol.198
, Issue.2
, pp. 226-233
-
-
Nachamkin, I.1
Shadomy, S.V.2
Moran, A.P.3
Cox, N.4
Fitzgerald, C.5
Ung, H.6
Corcoran, A.T.7
Iskander, J.K.8
Schonberger, L.B.9
Chen, R.T.10
-
69
-
-
63449100805
-
Vaccines for lymphomas: Idiotype vaccines and beyond
-
Houot R, Levy R. Vaccines for lymphomas: idiotype vaccines and beyond. Blood Rev 2009; 23:137-142
-
(2009)
Blood Rev
, vol.23
, pp. 137-142
-
-
Houot, R.1
Levy, R.2
-
70
-
-
57749203373
-
Therapeutic potential of vaccines in the management of hypertension
-
Brown MJ. Therapeutic potential of vaccines in the management of hypertension. Drugs 2008; 68:2557-2560
-
(2008)
Drugs
, vol.68
, pp. 2557-2560
-
-
Brown, M.J.1
-
72
-
-
58149307496
-
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
-
Baxevanis CN, Perez SA, Papamichail M. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Cancer Immunol Immunother 2009; 58:317-324
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 317-324
-
-
Baxevanis, C.N.1
Perez, S.A.2
Papamichail, M.3
-
73
-
-
55549114992
-
Structure-based antigen design: A strategy for next generation vaccines
-
Dormitzer PR, Ulmer JB, Rappuoli R. Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol 2008; 26:659-667
-
(2008)
Trends Biotechnol
, vol.26
, pp. 659-667
-
-
Dormitzer, P.R.1
Ulmer, J.B.2
Rappuoli, R.3
-
74
-
-
49649110168
-
Immunochemical termination of self-tolerance
-
Grunewald J, Tsao ML, Perera R, Dong L, Niessen F, Wen BG, et al. Immunochemical termination of self-tolerance. Proc Natl Acad Sci USA 2008; 105:11276-11280
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 11276-11280
-
-
Grunewald, J.1
Tsao, M.L.2
Perera, R.3
Dong, L.4
Niessen, F.5
Wen, B.G.6
-
75
-
-
63149104746
-
Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids
-
Grunewald J, Hunt GS, Dong L, Niessen F, Wen BG, Tsao ML, et al. Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids. Proc Natl Acad Sci USA 2009; 106:4337-4342
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 4337-4342
-
-
Grunewald, J.1
Hunt, G.S.2
Dong, L.3
Niessen, F.4
Wen, B.G.5
Tsao, M.L.6
-
76
-
-
70449701456
-
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
-
Xiao X, Chen W, Feng Y, Zhu Z, Prabakaran P, Wang Y, et al. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens. Biochem Biophys Res Commun 2009; 390:404-409
-
(2009)
Biochem Biophys Res Commun
, vol.390
, pp. 404-409
-
-
Xiao, X.1
Chen, W.2
Feng, Y.3
Zhu, Z.4
Prabakaran, P.5
Wang, Y.6
-
77
-
-
34547500771
-
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
-
DOI 10.1073/pnas.0701000104
-
Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci USA 2007; 104:12123-12128 (Pubitemid 47185640)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.29
, pp. 12123-12128
-
-
Zhu, Z.1
Chakraborti, S.2
He, Y.3
Roberts, A.4
Sheahan, T.5
Xiao, D.6
Hensley, L.E.7
Prabakaran, P.8
Rockx, B.9
Sidorov, I.A.10
Corti, O.11
Vogel, L.12
Feng, Y.13
Kim, J.-O.14
Wang, L.-F.15
Baric, R.16
Lanzavecchia, A.17
Curtis, K.M.18
Nabel, G.J.19
Subbarao, K.20
Jiang, S.21
Dimitrov, D.S.22
more..
-
78
-
-
30344474011
-
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
-
DOI 10.1128/JVI.80.2.891-899.2006
-
Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol 2006; 80:891-899 (Pubitemid 43062901)
-
(2006)
Journal of Virology
, vol.80
, Issue.2
, pp. 891-899
-
-
Zhu, Z.1
Dimitrov, A.S.2
Bossart, K.N.3
Crameri, G.4
Bishop, K.A.5
Choudhry, V.6
Mungall, B.A.7
Feng, Y.-R.8
Choudhary, A.9
Zhang, M.-Y.10
Feng, Y.11
Wang, L.-F.12
Xiao, X.13
Eaton, B.T.14
Broder, C.C.15
Dimitrov, D.S.16
-
79
-
-
65949114941
-
All known cross reactive HIV-1 neutralizing antibodies are highly divergent from germline and their elicitation may require prolonged periods of time
-
Chen W, Zhu Z, Zhang M, Macagno A, Prabakaran P, Owens J, et al. All known cross reactive HIV-1 neutralizing antibodies are highly divergent from germline and their elicitation may require prolonged periods of time. AIDS Res Hum Retroviruses 2008; 24:11-12
-
(2008)
AIDS Res Hum Retroviruses
, vol.24
, pp. 11-12
-
-
Chen, W.1
Zhu, Z.2
Zhang, M.3
Macagno, A.4
Prabakaran, P.5
Owens, J.6
-
80
-
-
77953655567
-
Maturation pathways of cross-reactive HIV-1 neutralizing antibodies
-
Xiao X, Chen W, Feng Y, Dimitrov DS. Maturation pathways of cross-reactive HIV-1 neutralizing antibodies. Viruses 2009; 1:802-817
-
(2009)
Viruses
, vol.1
, pp. 802-817
-
-
Xiao, X.1
Chen, W.2
Feng, Y.3
Dimitrov, D.S.4
-
81
-
-
0033367383
-
The immunome
-
Pederson T. The immunome. Mol Immunol 1999; 36:1127-1128
-
(1999)
Mol Immunol
, vol.36
, pp. 1127-1128
-
-
Pederson, T.1
-
82
-
-
63849131879
-
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
-
Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009; 458:636-640
-
(2009)
Nature
, vol.458
, pp. 636-640
-
-
Scheid, J.F.1
Mouquet, H.2
Feldhahn, N.3
Seaman, M.S.4
Velinzon, K.5
Pietzsch, J.6
-
83
-
-
0041689676
-
Predominant autoantibody production by early human B cell precursors
-
DOI 10.1126/science.1086907
-
Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374-1377 (Pubitemid 37075812)
-
(2003)
Science
, vol.301
, Issue.5638
, pp. 1374-1377
-
-
Wardemann, H.1
Yurasov, S.2
Schaefer, A.3
Young, J.W.4
Meffre, E.5
Nussenzweig, M.C.6
-
84
-
-
65649122270
-
High-throughput sequencing of the zebrafish antibody repertoire
-
Weinstein JA, Jiang N, White RA, III, Fisher DS, Quake SR. High-throughput sequencing of the zebrafish antibody repertoire. Science 2009; 324:807-810
-
(2009)
Science
, vol.324
, pp. 807-810
-
-
Weinstein, J.A.1
Jiang, N.2
White III, R.A.3
Fisher, D.S.4
Quake, S.R.5
-
85
-
-
73949116413
-
Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
-
Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci USA 2009; 106:20216-20221
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 20216-20221
-
-
Glanville, J.1
Zhai, W.2
Berka, J.3
Telman, D.4
Huerta, G.5
Mehta, G.R.6
|